Europe
Insilico Biotechnology AG announces the opening of their first subsidiary in the United States, located in Boston, MA.
The month of February ended with a flurry of clinical trial announcements. Here’s a look.
The novel coronavirus that causes the disease COVID-19 continues to spread and has now been diagnosed in more than 50 countries.
It marks the first time researchers have been able to establish a direct link between microbes living in the body and genetic alterations that can drive cancer and could lead to new treatments for colorectal cancer.
Abivax SA announced dosing of the first patient in a U.S. Phase 1/2 clinical trial of ABX196 to treat patients with hepatocellular carcinoma, the most common form of liver cancer..
MassBio® announced the two keynote speakers for its annual State of Possible Conference taking place March 25-26, 2020 at the Royal Sonesta in Cambridge: Billy Starr, Founder and Executive Director, Pan-Mass Challenge; and Susan Hockfield, Ph.D., President Emerita, MIT.
Biopharma and life sciences strengthen their executive leadership teams and boards with this week’s Movers & Shakers.
A look at how two biotech professionals made the transition from research to inspiring students as biotech teachers with the help of EnCorps STEM Teachers Program.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
The green light from the U.S. Food and Drug Administration marks the first approval for U.K.-based Acacia.
PRESS RELEASES